SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Apricus Biosciences
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: mokelumne river5/28/2015 4:02:49 PM
  Read Replies (2) of 2026
 
Pasco packed a lot of words into the presentation this morning. Same basic message but each time it gets a little smoother. Seems like the Fispemifene story gets a little stronger each time.

I heard about a million Vitaros units made thus far with 715K shipped and the balance will be shipped this quarter (next month) "primarily to support upcoming launches" so I see a bunch of those going to France.

Touching story at the very end about his lunch with a woman who has Reynaud's and is the president of a Raynaud's association. Her ordering water in a stemmed wine glass to avoid a cold contact drove the point home. I wish that RayVa was on a little faster track than approval in 2017. But it should be a solid asset and I think should quickly generate a lot of cash when marketed.

I didn't catch what Aprilov reported on ihub, that Pascoe may be looking for some other "lifestyle" drug acquisitions. May have been there and I missed it on the replay.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News